Daniel C Moreira, Federico Antillón-Klussmann, Roy Rosado, Claudia Garrido, Oscar González-Ramella, Violeta Salceda-Rivera, Luiz Fernando Lopes, Monica Cypriano, Fabiana Morosini, Guillermo Chantada, Shirley Montufar, Allyson Andujar, Leeanna Fox Irwin, Jordan Horner, Paola Friedrich, Saman K Hashmi, Carlos Rodríguez-Galindo
{"title":"Building Pediatric Hematology/Oncology Workforce Capacity in Latin America.","authors":"Daniel C Moreira, Federico Antillón-Klussmann, Roy Rosado, Claudia Garrido, Oscar González-Ramella, Violeta Salceda-Rivera, Luiz Fernando Lopes, Monica Cypriano, Fabiana Morosini, Guillermo Chantada, Shirley Montufar, Allyson Andujar, Leeanna Fox Irwin, Jordan Horner, Paola Friedrich, Saman K Hashmi, Carlos Rodríguez-Galindo","doi":"10.1002/pbc.32135","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study aimed to assess five pediatric hematology/oncology fellowship programs in Latin America by analyzing the profile of trainees and graduates, and their integration into the workforce.</p><p><strong>Methods: </strong>To train pediatric hematologists/oncologists, the St. Jude Global Academy collaborates with five institutions in Latin America: Unidad Nacional de Oncología Pediátrica (Guatemala), Hospital Civil de Guadalajara (Mexico), Hospital Pereira Rossell (Uruguay), Hospital Oncológico de Barretos (Brazil), and GRAACC (Brazil). Data on the origin of graduates, current job roles, and responsibilities were assessed.</p><p><strong>Results: </strong>Between 2003 and 2024, 110 physicians from 14 countries in Latin America started training in the five programs. Sixty-eight (61.8%) physicians completed training, while 36 (32.7%) are still currently in training. Six trainees (5.5%) withdrew from training prior to completion. Of 59 survey respondents, 47 (79.7%) currently work at a pediatric cancer unit. Thirty-seven (62.7%) graduates started working in pediatric oncology immediately after finishing training. The mean time for the 47 graduates working in pediatric cancer units to find a position was 0.18 years. After entering the pediatric oncology workforce, the mean time dedicated to pediatric oncology was 52.0%, with 15.5% spent on benign hematology, 12.8% on other clinical areas, 9.2% on administrative tasks, 6.9% on teaching, and 4.2% on research. Twenty-six (44%) graduates currently have a leadership role at their institutions.</p><p><strong>Conclusion: </strong>The five programs have trained Latin American specialists to care for children with cancer, with high integration into the pediatric oncology workforce. Graduates now contribute across the region, though further analyses are needed to define a comprehensive regional workforce strategy.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32135"},"PeriodicalIF":2.3000,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pbc.32135","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: This study aimed to assess five pediatric hematology/oncology fellowship programs in Latin America by analyzing the profile of trainees and graduates, and their integration into the workforce.
Methods: To train pediatric hematologists/oncologists, the St. Jude Global Academy collaborates with five institutions in Latin America: Unidad Nacional de Oncología Pediátrica (Guatemala), Hospital Civil de Guadalajara (Mexico), Hospital Pereira Rossell (Uruguay), Hospital Oncológico de Barretos (Brazil), and GRAACC (Brazil). Data on the origin of graduates, current job roles, and responsibilities were assessed.
Results: Between 2003 and 2024, 110 physicians from 14 countries in Latin America started training in the five programs. Sixty-eight (61.8%) physicians completed training, while 36 (32.7%) are still currently in training. Six trainees (5.5%) withdrew from training prior to completion. Of 59 survey respondents, 47 (79.7%) currently work at a pediatric cancer unit. Thirty-seven (62.7%) graduates started working in pediatric oncology immediately after finishing training. The mean time for the 47 graduates working in pediatric cancer units to find a position was 0.18 years. After entering the pediatric oncology workforce, the mean time dedicated to pediatric oncology was 52.0%, with 15.5% spent on benign hematology, 12.8% on other clinical areas, 9.2% on administrative tasks, 6.9% on teaching, and 4.2% on research. Twenty-six (44%) graduates currently have a leadership role at their institutions.
Conclusion: The five programs have trained Latin American specialists to care for children with cancer, with high integration into the pediatric oncology workforce. Graduates now contribute across the region, though further analyses are needed to define a comprehensive regional workforce strategy.
背景:本研究旨在通过分析实习生和毕业生的概况以及他们融入劳动力的情况来评估拉丁美洲的五个儿科血液学/肿瘤学奖学金项目。方法:为了培训儿科血液学家/肿瘤学家,圣裘德全球学院与拉丁美洲的五家机构合作:国立医院Oncología Pediátrica(危地马拉)、瓜达拉哈拉民间医院(墨西哥)、佩雷拉·罗塞尔医院(乌拉圭)、Oncológico de Barretos医院(巴西)和GRAACC(巴西)。对毕业生的来源、目前的工作角色和职责进行了评估。结果:2003年至2024年间,来自拉丁美洲14个国家的110名医生开始在这五个项目中接受培训。68名(61.8%)医生完成培训,36名(32.7%)医生仍在接受培训。6名受训人员(5.5%)在培训结束前退出。在59名调查对象中,47名(79.7%)目前在儿科癌症部门工作。37名(62.7%)毕业生在完成培训后立即进入儿科肿瘤学工作。在儿科癌症部门工作的47名毕业生找到工作的平均时间为0.18年。进入儿科肿瘤工作队伍后,平均用于儿科肿瘤的时间占52.0%,其中15.5%用于良性血液学,12.8%用于其他临床领域,9.2%用于行政任务,6.9%用于教学,4.2%用于研究。目前,26名(44%)毕业生在所在机构担任领导职务。结论:这五个项目培训了拉丁美洲的专家来照顾患有癌症的儿童,并高度融入儿科肿瘤学工作队伍。毕业生现在为整个地区做出贡献,尽管需要进一步分析以确定全面的区域劳动力战略。
期刊介绍:
Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.